GENEDX HOLDINGS CORP (WGS) Stock Price, Quote, News and Overview
NASDAQ:WGS - Nasdaq - US81663L2007 - Common Stock - Currency: USD
WGS Quote, Performance and Key Statistics
NASDAQ:WGS (5/8/2025, 1:47:29 PM)
57.41
+0.07 (+0.12%)
The current stock price of WGS is 57.41 USD. In the past month the price decreased by -33.29%. In the past year, price increased by 176.34%.
WGS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 12.2 | 91.30B | ||
| CVS | CVS HEALTH CORP | 10.74 | 86.22B | ||
| LH | LABCORP HOLDINGS INC | 17.04 | 21.01B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.24 | 19.74B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 17.65 | 16.57B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 128.74 | 13.97B | ||
| HIMS | HIMS & HERS HEALTH INC | 76.34 | 11.78B | ||
| DVA | DAVITA INC | 15.29 | 11.17B | ||
| CHE | CHEMED CORP | 24.32 | 8.39B | ||
| CRVL | CORVEL CORP | 27.18 | 5.84B | ||
| OPCH | OPTION CARE HEALTH INC | 23.6 | 5.26B | ||
| GH | GUARDANT HEALTH INC | N/A | 5.09B |
Related stock screener links
About WGS
Company Profile
GeneDx Holdings Corp. operates as a health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,000 full-time employees. The company went IPO on 2020-09-04. The firm operates, through its subsidiary GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. The company operates through the GeneDx segment. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. The company offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. The company provides carrier/variant-specific testing, targeted mosaic variant testing, and others.
Company Info
GENEDX HOLDINGS CORP
333 Ludlow Street, North Tower, 6Th Floor
Stamford CONNECTICUT US
Employees: 1000
Phone: 18887291206
GENEDX HOLDINGS CORP / WGS FAQ
What is the stock price of GENEDX HOLDINGS CORP today?
The current stock price of WGS is 57.41 USD. The price increased by 0.12% in the last trading session.
What is the ticker symbol for GENEDX HOLDINGS CORP stock?
The exchange symbol of GENEDX HOLDINGS CORP is WGS and it is listed on the Nasdaq exchange.
On which exchange is WGS stock listed?
WGS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GENEDX HOLDINGS CORP stock?
10 analysts have analysed WGS and the average price target is 98.6 USD. This implies a price increase of 71.75% is expected in the next year compared to the current price of 57.41. Check the GENEDX HOLDINGS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GENEDX HOLDINGS CORP worth?
GENEDX HOLDINGS CORP (WGS) has a market capitalization of 1.64B USD. This makes WGS a Small Cap stock.
How many employees does GENEDX HOLDINGS CORP have?
GENEDX HOLDINGS CORP (WGS) currently has 1000 employees.
Is GENEDX HOLDINGS CORP (WGS) expected to grow?
The Revenue of GENEDX HOLDINGS CORP (WGS) is expected to grow by 23.68% in the next year. Check the estimates tab for more information on the WGS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GENEDX HOLDINGS CORP (WGS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of WGS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of WGS, evaluating the profitability, health, valuation and growth aspects
- GENEDX HOLDINGS CORP (WGS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GENEDX HOLDINGS CORP (WGS) Sales and EPS estimates to see what analysts future expectations are.
- GENEDX HOLDINGS CORP (WGS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GENEDX HOLDINGS CORP (WGS) Insider and Institutional Ownership to learn about the owners and their transactions.
- GENEDX HOLDINGS CORP (WGS) Stock Chart to make your own analysis
- GENEDX HOLDINGS CORP (WGS) Latest news and press-releases to stay up to date.
Does GENEDX HOLDINGS CORP (WGS) stock pay dividends?
WGS does not pay a dividend.
When does GENEDX HOLDINGS CORP (WGS) report earnings?
GENEDX HOLDINGS CORP (WGS) will report earnings on 2025-07-28, after the market close.
What is the Price/Earnings (PE) ratio of GENEDX HOLDINGS CORP (WGS)?
The PE ratio for GENEDX HOLDINGS CORP (WGS) is 68.35. This is based on the reported non-GAAP earnings per share of 0.84 and the current share price of 57.41 USD. Check the full fundamental report for a full analysis of the valuation metrics for WGS.
What is the Short Interest ratio of GENEDX HOLDINGS CORP (WGS) stock?
The outstanding short interest for GENEDX HOLDINGS CORP (WGS) is 13.03% of its float. Check the ownership tab for more information on the WGS short interest.
WGS Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to WGS. When comparing the yearly performance of all stocks, WGS is one of the better performing stocks in the market, outperforming 98.28% of all stocks.
WGS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to WGS. The financial health of WGS is average, but there are quite some concerns on its profitability.
WGS Financial Highlights
Over the last trailing twelve months WGS reported a non-GAAP Earnings per Share(EPS) of 0.84. The EPS increased by 124.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.47% | ||
| ROE | -21.32% | ||
| Debt/Equity | 0.29 |
WGS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to WGS. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 308.39% and a revenue growth 23.68% for WGS